![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_r3xPTp_zHT5BHIVKd659Kuml7A8D_Yq9W383BuRU8GiWJ1QDYZVB9NfQ_A0DUEwiGbYVKjo-hkLL9HXsRMSVQ2ZmFAV8BpdG0PLkDpA1X364ESPlOGYbb82OqRlxsCChSFc3rinYiua5/s320/mw-mast-tag2.gif)
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhZ8PLBnhmtIeX8iGTXgDknMGgmM-i77IxX6SAHFZixhb_RiUBumjRtUlRCGa1CnwmmKMzXiUfHE9s-4fhgtA1W6BzZlkEW8ieO-5UVE9csSWDxOXcA1SnnGiZf2QCVbAx43nq484EGBIa4/s320/mw_logo_ani_160px.gif)
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg9chapt6yiViiVe51Lh01WPNfHpzBb2OBFazpm1z5w3o5Qn31lVHUCjgT_FT38It7NNbFw4EMptSAB8LK5L98dSvzU4VJu-LZpk1N-LEPnNorR42uQ-lmk9l-ctzSmtxdo5WKDQxEpz1dW/s320/fda_mast_02.gif)
The February 2009 posting includes 46 drug products with safety labeling changes to the following sections: BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT PACKAGE INSERT, and MEDICATION GUIDE.
The "Summary Page" provides a listing of drug names and safety labeling sections revised: http://www.fda.gov/medwatch/safety/2009/feb09_quickview.htm
The "Detailed View Page" identifies safety labeling sections and subsections revised along with a brief summary of new or modified safety information to the BOXED WARNING, CONTRAINDICATIONS, and/or WARNINGS sections: http://www.fda.gov/medwatch/safety/2009/feb09.htm
The following 10 drugs had modifications to the BOXED WARNING, CONTRAINDICATIONS, and WARNINGS sections:
* Fludara,
* Novantrone,
* Furadantin,
* Heparin Sodium,
* Implanon,
* Luvox,
* Prograf,
* Toprol XL,
* Tracleer, and
* Zerit
abrir aquí:
MedWatch - February 2009 Safety-Related Drug Labeling Changes - Detailed
No hay comentarios:
Publicar un comentario